Although the use of GM-CSF significantly reduced the frequency of grade 4 neutrophils (18% vs. 24%, P = 0.01), it increased the incidence of grade 3 + thrombocytopenia (54% vs. 12%, P < 0.001). Here, CSF2 is linked to Thrombocytopenia.